Anemia is Associated with an Adverse Outcome in Patients with Atrial Fibrillation: Insights Form the Re-ly Trial

被引：0
|
作者：
Westenbrink, B. Daan [1 ]
Alings, Marco [2 ]
Connolly, Stuart [3 ,4 ]
Eikelboom, Iohn [5 ]
Ezekowitz, Michael D. [6 ]
Oldgren, Jonas [5 ]
Yang, Sean [3 ,4 ]
Pogue, Janice [3 ,4 ]
Yusuf, Salim [3 ,4 ]
Wallentin, Lars [7 ]
van Gilst, Wiek H. [1 ]
机构：
[1] Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands
[2] Amphia Hosp, Breda, Netherlands
[3] Populat Hlth Rsch Inst, Hamilton, ON, Canada
[4] McMaster Univ, Hamilton, ON, Canada
[5] Uppsala Univ, Uppsala Clin Rsch Cntr, Uppsala, Sweden
[6] Lankenau Inst Med Res & Heart Cntr, Wynnewood, PA USA
[7] Uppsala Univ, Uppsala, Sweden
来源：
CIRCULATION | 2012年 / 126卷 / 21期
关键词：
Anticoagulants; Hemoglobin; Myocardial Infraction; Outcomes;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
18466
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Comparison of Contemporary Bleeding Risk Scores in Patients With Non-Valvular Atrial Fibrillation Treated With Dabigatran or Warfarin: Insights From the RE-LY Trial
    Proietti, Marco
    Hijazi, Ziad
    Andersson, Ulrika
    Connolly, Stuart J.
    Eikelboom, John W.
    Ezekowitz, Michael D.
    Lane, Deirdre A.
    Oldgren, Jonas
    Roldan, Vanessa
    Yusuf, Salim
    Wallentin, Lars
    CIRCULATION, 2016, 134
  • [32] Dabigatran compared to warfarin in patients with atrial fibrillation and prior TIA or stroke: the RE-LY study
    Diener, H. C.
    Connolly, S. J.
    Ezekowitz, M.
    Yusuf, S.
    Wallentin, L.
    Reilly, P.
    Pogue, J.
    Wang, S.
    Xavier, D.
    Di Pasquale, G.
    JOURNAL OF NEUROLOGY, 2010, 257 : S31 - S31
  • [33] Alcohol Consumption and Cardiovascular Outcomes in Patients With Atrial Fibrillation; a RE-LY AF Registry Analysis
    Oraii, Alireza
    Kirabo, Faith
    Balasubramanian, Kumar
    Benz, Alexander P.
    Wong, Jorge A.
    McIntyre, William F.
    Conen, David
    Healey, Jeff S.
    CIRCULATION, 2022, 146
  • [34] Importance of persistent elevation of cardiac biomarkers in atrial fibrillation: a RE-LY substudy
    Hijazi, Ziad
    Oldgren, Jonas
    Andersson, Ulrika
    Connolly, Stuart J.
    Ezekowitz, Michael D.
    Hohnloser, Stefan H.
    Reilly, Paul A.
    Siegbahn, Agneta
    Yusuf, Salim
    Wallentin, Lars
    HEART, 2014, 100 (15) : 1193 - 1200
  • [35] Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial
    Diener, Hans Chnstoph
    Connolly, Stuart J.
    Ezekowitz, Michael D.
    Wallentin, Lars
    Reilly, Paul A.
    Yang, Sean
    Xavier, Denis
    Di Pasquale, Giuseppe
    Yusuf, Salim
    LANCET NEUROLOGY, 2010, 9 (12): : 1157 - 1163
  • [36] Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation - a RE-LY Trial Analysis
    Hijazi, Ziad
    Hohnloser, Stefan H.
    Oldgren, Jonas
    Andersson, Ulrika
    Connolly, Stuart J.
    Eikelboom, John W.
    Ezekowitz, Michael D.
    Reilly, Paul A.
    Siegbahn, Agneta
    Yusuf, Salim
    Wallentin, Lars
    CIRCULATION, 2013, 128 (22)
  • [37] Analysis of Upper Gastrointestinal Adverse Events Among Patients Given Dabigatran in the RE-LY Trial
    Bytzer, Peter
    Connolly, Stuart J.
    Yang, Sean
    Ezekowitz, Michael
    Formella, Stephan
    Reilly, Paul A.
    Aisenberg, James
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (03) : 246 - +
  • [38] Reweighting Oranges to Apples: Transported RE-LY Trial Versus Nonexperimental Effect Estimates of Anticoagulation in Atrial Fibrillation
    Webster-Clark, Michael
    Lund, Jennifer L.
    Sturmer, Til
    Poole, Charles
    Simpson, Ross J.
    Edwards, Jessie K.
    EPIDEMIOLOGY, 2020, 31 (05) : 605 - 613
  • [39] Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials
    Aulin, Julia
    Hijazi, Ziad
    Siegbahn, Agneta
    Andersson, Ulrika
    Alexander, John H.
    Connolly, Stuart J.
    Ezekowitz, Michael D.
    Gersh, Bernard J.
    Granger, Christopher B.
    Horowitz, John
    Hylek, Elaine M.
    Lopes, Renato D.
    Yusuf, Salim
    Wallentin, Lars
    Oldgren, Jonas
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (09) : 2287 - 2295
  • [40] A novel biomarker-based risk score to predict death in patients with atrial fibrillation: Insights from the ARISTOTLE and RE-LY trials
    Hijazi, Z.
    Oldgren, J.
    Lindback, J.
    Alexander, J. H.
    Connolly, S. J.
    Eikelboom, J. W.
    Ezekowitz, M. D.
    Hylek, E. M.
    Lopes, R. D.
    Yusuf, S.
    Granger, C. B.
    Siegbahn, A.
    Wallentin, L.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1221 - 1221
12345